Novo Nordisk | NVO - Interest Income

Stock Price
44.31
Daily Change
-1.53 -3.34%
Monthly
8.39%
Yearly
-31.15%
Q2 Forecast
42.62

Novo Nordisk reported DKK3.42B in Interest Income for its fiscal quarter ending in March of 2025.





Interest Income Change Date
Aurora Cannabis CAD 1.85M 120K Sep/2025
Bausch Health Companies USD 9M 6M Dec/2025
Corcept Therapeutics USD 5.42M 399K Dec/2025
Drreddys Laboratories INR 796M 332M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Merck USD 69M 27M Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Novo Nordisk DKK 3.42B 2.04B Mar/2025
Pacira USD 2.3M 6.24M Dec/2025
Phibro Animal Health USD 0.08 0.09 Dec/2024
Sanofi EUR 33M 81M Dec/2025
Supernus Pharmaceuticals USD 2.02M 254K Dec/2025
Zoetis USD 25M 1000K Dec/2025